Dentsply Sirona is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries.
| Revenue (TTM) | $3.68B |
| Gross Profit (TTM) | $1.80B |
| EBITDA | $556.00M |
| Operating Margin | 3.41% |
| Return on Equity | -37.70% |
| Return on Assets | 2.26% |
| Revenue/Share (TTM) | $18.44 |
| Book Value | $6.71 |
| Price-to-Book | 1.98 |
| Price-to-Sales (TTM) | 0.73 |
| EV/Revenue | 1.291 |
| EV/EBITDA | 25.40 |
| Quarterly Earnings Growth (YoY) | 15.20% |
| Quarterly Revenue Growth (YoY) | 0.10% |
| Shares Outstanding | $200.33M |
| Float | $199.22M |
| % Insiders | 0.63% |
| % Institutions | 110.39% |
Volatility is currently expanding
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
CHARLOTTE, N.C., July 28, 2026 (GLOBE NEWSWIRE) -- Dentsply Sirona, the world's largest diversified manufacturer of professional dental products and technologies, today announced an expansion of its long-standing relationship with Medline Sinclair, one of Canada's leading full-service dental distributors.
CHARLOTTE, N.C., July 21, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to review its second quarter 2026 financial results. Financial earnings materials will be made available on the Investors section of the Company's website at https://investor.dentsplysirona.com prior to the call.
This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients. This milestone reflects PDS Health's continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for patients.
XRAY leans on its Return-to-Growth plan, new distributor wins and AI-enabled launches ??? while forex and Europe demand softness linger.
Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses Brings more than 25 years of experience leading transformation, capital deployment, and growth initiatives across global businesses
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Dentsply (XRAY) reported earnings 30 days ago. What's next for the stock?
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET.
DENTSPLY SIRONA stock slips after Q1 earnings miss estimates as margin pressure offsets revenue growth in key healthcare segments.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on XRAY and any ticker you trade — then tracks every position and per-strategy win rate.
